Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 3Incyte Biosciences Distribution

02 6Incyte Biosciences Distribution B.V.

03 3Incyte Biosciences Distribution BV

04 3Incyte Biosciences Distribution Bv

05 3Incyte Biosciences International S?rl

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

SCOPE Summit
Not Confirmed
arrow
arrow
SCOPE Summit
Not Confirmed

Pemigatinib

Brand Name : Pemazyre

Dosage Form : Tablet

Dosage Strength : 13.5mg

Packaging :

Approval Date : 26/03/2021

Application Number : 20191122000062

Regulatory Info : Approved

Registration Country : Sweden

blank

02

SCOPE Summit
Not Confirmed
arrow
arrow
SCOPE Summit
Not Confirmed

Pemigatinib

Brand Name : Pemazyre

Dosage Form : Tablet

Dosage Strength : 4.5mg

Packaging :

Approval Date : 26/03/2021

Application Number : 20191122000048

Regulatory Info : Approved

Registration Country : Sweden

blank

03

SCOPE Summit
Not Confirmed
arrow
arrow
SCOPE Summit
Not Confirmed

Pemigatinib

Brand Name : Pemazyre

Dosage Form : Tablet

Dosage Strength :

Packaging :

Approval Date : 26/03/2021

Application Number : 20191122000055

Regulatory Info : Approved

Registration Country : Sweden

blank

04

SCOPE Summit
Not Confirmed
arrow
arrow
SCOPE Summit
Not Confirmed

Pemigatinib

Brand Name : Pemazyre

Dosage Form : Tablet

Dosage Strength : 4.5mg

Packaging :

Approval Date : 13/07/2021

Application Number : 68143

Regulatory Info : Limited-Term

Registration Country : Switzerland

blank

05

SCOPE Summit
Not Confirmed
arrow
arrow
SCOPE Summit
Not Confirmed

Pemigatinib

Brand Name : Pemazyre

Dosage Form : Tablet

Dosage Strength : 9mg

Packaging :

Approval Date : 13/07/2021

Application Number : 68143

Regulatory Info : Limited-Term

Registration Country : Switzerland

blank

06

SCOPE Summit
Not Confirmed
arrow
arrow
SCOPE Summit
Not Confirmed

Pemigatinib

Brand Name : Pemazyre

Dosage Form : Tablet

Dosage Strength : 13.5mg

Packaging :

Approval Date : 13/07/2021

Application Number : 68143

Regulatory Info : Limited-Term

Registration Country : Switzerland

blank

07

SCOPE Summit
Not Confirmed
arrow
arrow
SCOPE Summit
Not Confirmed

Pemigatinib

Brand Name : Pemazyre

Dosage Form : Tablet

Dosage Strength : 13.5mg

Packaging :

Approval Date :

Application Number :

Regulatory Info : Marketed

Registration Country : Norway

blank

08

SCOPE Summit
Not Confirmed
arrow
arrow
SCOPE Summit
Not Confirmed

Pemigatinib

Brand Name : Pemazyre

Dosage Form : Tablet

Dosage Strength : 4.5mg

Packaging :

Approval Date :

Application Number :

Regulatory Info : Marketed

Registration Country : Norway

blank

09

SCOPE Summit
Not Confirmed
arrow
arrow
SCOPE Summit
Not Confirmed

Pemigatinib

Brand Name : Pemazyre

Dosage Form : Tablet

Dosage Strength :

Packaging :

Approval Date :

Application Number :

Regulatory Info : Marketed

Registration Country : Norway

blank

10

SCOPE Summit
Not Confirmed
arrow
arrow
SCOPE Summit
Not Confirmed

Pemigatinib

Brand Name : Pemazyre

Dosage Form : Tablet

Dosage Strength : 135mg

Packaging :

Approval Date :

Application Number :

Regulatory Info : Prescription

Registration Country : Estonia

blank